Advancing clinical development through innovative trial design

Innovative trial design has the potential to accelerate the delivery of novel treatments to patients. But intensive planning and close interaction with regulatory agencies is required to ensure the successful execution. Discover more about innovative trial design, including platform trials, basket trials, umbrella trials, enrichment designs, and adaptive trials. Practical examples of each type of trial design and their applications in different therapeutic areas are explored, to demonstrate how therapies can be delivered to patients faster and more efficiently.

Open PDF

Return to Insights Center

Related Insights


New FDA draft guidance: Implications for simplifying interchangeability for biosimilars in the US

Jul 16, 2024


Relyvrio Approval: Lessons Learned

Oct 31, 2022


RBQM Podcast Series | Episode 3: Staying within the Guardrails: How to Push the Boundaries in a Highly Regulated Industry

Jun 16, 2022


8 things you need to know about eCTDs in China

Jul 1, 2022


Preparing for the New Era of Hybrid Regulatory Inspections

Jul 11, 2022


EU Orphan Drug Designation – overcoming regulatory challenges

Jul 20, 2022


Cell & Gene Therapies: A Regulatory Update

Jul 22, 2022


U.S. drug price reform of 2022: What does the Inflation Reduction Act mean for drug manufacturers?

Aug 17, 2022


Q&A Project Optimus: What you need to know

Oct 11, 2022


Five strategies for meeting the requirements of Project Optimus and improving the chances of approval

Nov 10, 2022


New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle

May 10, 2022


Are you using real-world evidence?

Feb 1, 2023